Stay updated on Aflibercept vs Bevacizumab vs Ranibizumab for DME Clinical Trial

Sign up to get notified when there's something new on the Aflibercept vs Bevacizumab vs Ranibizumab for DME Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Aflibercept vs Bevacizumab vs Ranibizumab for DME Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision label updated to v3.4.2, replacing the previous v3.4.1. This appears to be a minor version update with no changes to study data or page content.
    Difference
    0.0%
    Check dated 2026-02-13T17:44:59.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Minor update observed: revision from v3.4.0 to v3.4.1 with no observable changes to core content or user-facing features. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-06T11:16:49.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    Glossary toggle options (Show glossary / Hide glossary) were added and revision metadata updated to v3.4.0, replacing earlier items such as 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'. The changes are UI/metadata updates and do not modify the core study information or results.
    Difference
    0.2%
    Check dated 2026-01-23T03:16:48.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and v3.3.3 was removed, with no substantive changes to study content or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-16T01:35:59.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Added a consolidated 'Locations' section listing participating states and a revision tag (v3.3.3). Removed individual state location pages (Arizona Locations, California Locations, etc.) and the HHS Vulnerability Disclosure.
    Difference
    2%
    Check dated 2025-12-24T14:41:23.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    New notes clarify that publications are voluntarily provided by the study submitter and may be auto-filled from PubMed, with some items potentially not directly about the study. The revision tag has been updated to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T14:15:34.000Z thumbnail image

Stay in the know with updates to Aflibercept vs Bevacizumab vs Ranibizumab for DME Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Aflibercept vs Bevacizumab vs Ranibizumab for DME Clinical Trial page.